( en | de | ru )

 

Disambiguation of "Westermann, Frank"

Author of the publication

copydeleteadd this publication to your clipboard
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.

, , , , , , , , , , , , , and . Clin Cancer Res, 13 (16): 4695--4703 (August 2007)
DOI: 10.1158/1078-0432.CCR-06-2818

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Frank Westermann

Gerhard Westermann

Christa Westermann

Michael Westermann

Franz Westermann

 

Other publications of authors with the same name

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks, , , , , , , , , and 1 other author(s). Nat Med, 7 (6): 673--679 (June 2001)Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes., , , , , and . BMC Cancer, (2007)Equity price dynamics before and after the introduction of the Euro, and . CESifo working papers Univ., Center for Economic Studies, Munich, (2001)SeptemBear, , and . Münchener wirtschaftswissenschaftliche Beiträge Univ., Volkswirtschaftl. Fak., München, (2000)Decomposing the effects of financial liberalization: Crises vs. growth, , and . Journal of Banking & Finance, 30 (12): 3331--3348 (December 2006)Factor price equalization?, and . CESifo working paper series Univ., Center for Economic Studies, Munich, (2001)Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification., , , , , , , , , and 4 other author(s). J Clin Oncol, 24 (31): 5070--5078 (November 2006)High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status., , , , , , , , , and 4 other author(s). Clin Cancer Res, 13 (16): 4695--4703 (August 2007)Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease., , , , , , , , , and 1 other author(s). Cancer Lett, 250 (2): 250--267 (June 2007)High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma., , , , , , , , , and 8 other author(s). Clin Cancer Res, 17 (15): 5082--5092 (August 2011)